Literature DB >> 26486328

Long non-coding RNA small nucleolar RNA host gene 12 (SNHG12) promotes cell proliferation and migration by upregulating angiomotin gene expression in human osteosarcoma cells.

Wendong Ruan1, Pei Wang2, Shiqing Feng2, Yuan Xue2, Yulin Li2.   

Abstract

The long non-coding RNA (lncRNA) small nucleolar RNA host gene 12 (SNHG12) has a role in cell proliferation and migration. Angiomotin, encoded by the AMOT gene, is a protein that regulates the migration and organization of endothelial cells. SNHG12 and AMOT have been shown to play a role in a variety of human cancers but have yet to be studied in detail in human osteosarcoma. Tissue samples from primary osteosarcoma (n = 20) and adjacent normal tissues (n = 20), the osteosarcoma cell lines, SAOS-2, MG-63, U-2 OS, and the human osteoblast cell line hFOB (OB3) were studied using Western blot for angiomotin, and quantitative real-time polymerase chain reaction for the expression of SNHG12 and AMOT. The expression of SNHG12 was knocked down using RNA interference. Cell migration assays were performed. Cell apoptosis was studied using flow cytometry. SNHG12 and AMOT messenger RNA (mRNA) expression was upregulated in osteosarcoma tissues and cell lines when compared with normal tissues and cells. Upregulation of AMOT mRNA was associated with upregulation of SNHG12. Knockdown of SNHG12 reduced the expression of angiomotin in osteosarcoma cells and suppressed cell proliferation and migration but did not affect cell apoptosis. This preliminary study has shown that the lncRNA SNHG12 promotes cell proliferation and migration by upregulating AMOT gene expression in osteosarcoma cells in vivo and in vitro. Further studies are recommended to investigate the role of SNHG12 and AMOT expression in tumor cell proliferation and migration and angiogenesis in osteosarcoma and a range of malignant mesenchymal tumors.

Entities:  

Keywords:  AMOT; Cell migration; Cell proliferation; Long non-coding RNA; Osteosarcoma; Small nucleolar RNA host gene 12

Mesh:

Substances:

Year:  2015        PMID: 26486328     DOI: 10.1007/s13277-015-4256-7

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  30 in total

1.  Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

Authors:  Benjamin P Lewis; Christopher B Burge; David P Bartel
Journal:  Cell       Date:  2005-01-14       Impact factor: 41.582

2.  The p130 isoform of angiomotin is required for Yap-mediated hepatic epithelial cell proliferation and tumorigenesis.

Authors:  Chunling Yi; Zhewei Shen; Anat Stemmer-Rachamimov; Noor Dawany; Scott Troutman; Louise C Showe; Qin Liu; Akihiko Shimono; Marius Sudol; Lars Holmgren; Ben Z Stanger; Joseph L Kissil
Journal:  Sci Signal       Date:  2013-09-03       Impact factor: 8.192

3.  Osteosarcoma: the same old drugs or more?

Authors:  Stefan S Bielack; Neyssa Marina; Stefano Ferrari; Lee J Helman; Sigbjørn Smeland; Jeremy S Whelan; Gregory H Reaman
Journal:  J Clin Oncol       Date:  2008-06-20       Impact factor: 44.544

Review 4.  Molecular mechanisms of long noncoding RNAs.

Authors:  Kevin C Wang; Howard Y Chang
Journal:  Mol Cell       Date:  2011-09-16       Impact factor: 17.970

5.  A vaccine targeting angiomotin induces an antibody response which alters tumor vessel permeability and hampers the growth of established tumors.

Authors:  Maddalena Arigoni; Giuseppina Barutello; Stefania Lanzardo; Dario Longo; Silvio Aime; Claudia Curcio; Manuela Iezzi; Yujuan Zheng; Irmeli Barkefors; Lars Holmgren; Federica Cavallo
Journal:  Angiogenesis       Date:  2012-03-17       Impact factor: 9.596

Review 6.  Diagnosis and management of bone malignancy in adolescence.

Authors:  Jonathan S C Caudill; Carola A S Arndt
Journal:  Adolesc Med State Art Rev       Date:  2007-05

Review 7.  The hallmarks of cancer: a long non-coding RNA point of view.

Authors:  Tony Gutschner; Sven Diederichs
Journal:  RNA Biol       Date:  2012-06-01       Impact factor: 4.652

Review 8.  The genetic signatures of noncoding RNAs.

Authors:  John S Mattick
Journal:  PLoS Genet       Date:  2009-04-24       Impact factor: 5.917

Review 9.  Understanding the Biology of Bone Sarcoma from Early Initiating Events through Late Events in Metastasis and Disease Progression.

Authors:  Limin Zhu; Madonna M McManus; Dennis P M Hughes
Journal:  Front Oncol       Date:  2013-09-17       Impact factor: 6.244

10.  Long non-coding RNA HOTAIR promotes cell migration and invasion via down-regulation of RNA binding motif protein 38 in hepatocellular carcinoma cells.

Authors:  Chaofeng Ding; Shaobing Cheng; Zhe Yang; Zhen Lv; Heng Xiao; Chengli Du; Chuanhui Peng; Haiyang Xie; Lin Zhou; Jian Wu; Shusen Zheng
Journal:  Int J Mol Sci       Date:  2014-03-06       Impact factor: 5.923

View more
  42 in total

1.  A novel antisense long non-coding RNA SATB2-AS1 overexpresses in osteosarcoma and increases cell proliferation and growth.

Authors:  Si-Hong Liu; Jian-Wei Zhu; Hui-Hua Xu; Gui-Qiang Zhang; Yan Wang; Ya-Min Liu; Jun-Bo Liang; Yu-Xuan Wang; Yong Wu; Qi-Feng Guo
Journal:  Mol Cell Biochem       Date:  2017-02-11       Impact factor: 3.396

Review 2.  Emerging roles of non-coding RNAs in the pathogenesis, diagnosis and prognosis of osteosarcoma.

Authors:  Chongchong Wang; Juehua Jing; Li Cheng
Journal:  Invest New Drugs       Date:  2018-08-06       Impact factor: 3.850

3.  C-MYC-induced upregulation of lncRNA SNHG12 regulates cell proliferation, apoptosis and migration in triple-negative breast cancer.

Authors:  Ouchen Wang; Fan Yang; Yehuan Liu; Lin Lv; Ruimin Ma; Chuanzhi Chen; Jiao Wang; Qiufan Tan; Yue Cheng; Erjie Xia; Yizuo Chen; Xiaohua Zhang
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

Review 4.  MEG3: an Oncogenic Long Non-coding RNA in Different Cancers.

Authors:  Arwa Al-Rugeebah; Mohammed Alanazi; Narasimha Reddy Parine
Journal:  Pathol Oncol Res       Date:  2019-02-21       Impact factor: 3.201

5.  Long Non-coding RNA PVT1 Inhibits miR-30c-5p to Upregulate Rock2 to Modulate Cerebral Ischemia/Reperfusion Injury Through MAPK Signaling Pathway Activation.

Authors:  Hao Zhang; Minghong Li; Junquan Liang; Meng Li; Xiaoou Sun
Journal:  Mol Neurobiol       Date:  2021-08-26       Impact factor: 5.590

Review 6.  Long non-coding RNA small nucleolar RNA host genes: functions and mechanisms in hepatocellular carcinoma.

Authors:  Yuan Li; Xinxin Wang; Shiyong Chen; Biao Wu; Yu He; Xueqin Du; Xiaojun Yang
Journal:  Mol Biol Rep       Date:  2022-01-06       Impact factor: 2.316

7.  The Long Non-coding RNA SNHG12 Functions as a Competing Endogenous RNA to Modulate the Progression of Cerebral Ischemia/Reperfusion Injury.

Authors:  Hao Zhang; Yuan Liu; Meng Li; Gongfeng Peng; Tao Zhu; Xiaoou Sun
Journal:  Mol Neurobiol       Date:  2021-11-27       Impact factor: 5.590

Review 8.  Emerging roles for long noncoding RNAs in skeletal biology and disease.

Authors:  Nguyen P T Huynh; Britta A Anderson; Farshid Guilak; Audrey McAlinden
Journal:  Connect Tissue Res       Date:  2016-06-02       Impact factor: 3.417

9.  Small nucleolar host gene 6 promotes esophageal squamous cell carcinoma cell proliferation and inhibits cell apoptosis.

Authors:  Rui-Hua Fan; Jia-Ni Guo; Wei Yan; Ming-De Huang; Chang-Li Zhu; Yong-Mei Yin; Xiao-Fei Chen
Journal:  Oncol Lett       Date:  2018-02-20       Impact factor: 2.967

10.  N6-methyladenosine Modification-Related Long Non-Coding RNAs are Potential Biomarkers for Predicting the Prognosis of Patients With Osteosarcoma.

Authors:  Kun Yang; Fengyan Wang; Ke Li; Guoxuan Peng; Hua Yang; Hong Xu; Yang Xiang; Hong Sun
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.